Literature DB >> 14769376

Role of micro-opioid receptors in formalin-induced pain behavior in mice.

Cheng-Shui Zhao1, Yuan-Xiang Tao, Jill M Tall, David M Donovan, Richard A Meyer, Srinivasa N Raja.   

Abstract

Intraplantar formalin injection is widely used as an experimental model of tonic pain. We investigated the role of endogenous micro-opioid receptor mechanisms in formalin-induced nocifensive behavior in mice. The flinching response induced by formalin (2%, 20 microl) was studied in mice with normal (wild type, n = 8) and absent (homozygous micro-opioid receptor knockout, n = 8) micro-opioid receptor levels. The flinch responses were counted every 5 min for 60 min post-formalin injection. Lumbar spinal cord (L4, 5) was harvested 2 h post-formalin injection to examine c-Fos expression using immunohistochemistry. The effects of naloxone (5 mg/kg, sc) administered 30 min before the intraplantar formalin injection on the flinching response of wild-type mice (n = 7) were also recorded. The second-phase formalin response (10-60 min after formalin) was higher in homozygous micro-opioid receptor knockout mice compared to the wild-type mice (P < 0.01). Naloxone administration in wild-type mice before formalin injection resulted in pain behavior similar to that observed in homozygous micro-opioid receptor knockout mice (P > 0.05). The c-Fos expression induced by formalin injection in the knockout mice was not different from that observed in wild-type mice. Our results suggest that the endogenous micro-opioid system is activated by intraplantar formalin injection and exerts a tonic inhibitory effect on the pain behavior. These results suggest an important modulatory role of endogenous micro-opioid receptor mechanisms in tonic pain states.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14769376     DOI: 10.1016/S0014-4886(03)00346-7

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  7 in total

1.  MBD1 Contributes to the Genesis of Acute Pain and Neuropathic Pain by Epigenetic Silencing of Oprm1 and Kcna2 Genes in Primary Sensory Neurons.

Authors:  Kai Mo; Shaogen Wu; Xiyao Gu; Ming Xiong; Weihua Cai; Fidelis E Atianjoh; Emily E Jobe; Xinyu Zhao; Wei-Feng Tu; Yuan-Xiang Tao
Journal:  J Neurosci       Date:  2018-09-28       Impact factor: 6.167

Review 2.  Usefulness of knockout mice to clarify the role of the opioid system in chronic pain.

Authors:  Rafael Maldonado; Josep Eladi Baños; David Cabañero
Journal:  Br J Pharmacol       Date:  2018-01-06       Impact factor: 8.739

3.  Connections between EM2- and SP-containing terminals and GABAergic neurons in the mouse spinal dorsal horn.

Authors:  Dao-Shu Luo; Jing Huang; Yu-Lin Dong; Zhen-Yu Wu; Yan-Yan Wei; Ya-Cheng Lu; Ya-Yun Wang; Yuchio Yanagawa; Sheng-Xi Wu; Wei Wang; Yun-Qing Li
Journal:  Neurol Sci       Date:  2014-04-10       Impact factor: 3.307

4.  Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain.

Authors:  Alexander T Podolsky; Alexander Sandweiss; Jackie Hu; Edward J Bilsky; Jim P Cain; Vlad K Kumirov; Yeon Sun Lee; Victor J Hruby; Ruben S Vardanyan; Todd W Vanderah
Journal:  Life Sci       Date:  2013-09-29       Impact factor: 5.037

5.  Inhibitory effect of lidocaine on pain and itch using formalin-induced nociception and 5'-guanidinonaltrindole-induced scratching models in mice: behavioral and neuroanatomical evidence.

Authors:  Saadet Inan; Nae J Dun; Alan Cowan
Journal:  Eur J Pharmacol       Date:  2009-06-21       Impact factor: 4.432

6.  Comparison of morphine, oxycodone and the biased MOR agonist SR-17018 for tolerance and efficacy in mouse models of pain.

Authors:  Fani Pantouli; Travis W Grim; Cullen L Schmid; Agnes Acevedo-Canabal; Nicole M Kennedy; Michael D Cameron; Thomas D Bannister; Laura M Bohn
Journal:  Neuropharmacology       Date:  2020-12-17       Impact factor: 5.250

7.  Magnesium Salt, a Simple Strategy to Improve Methadone Analgesia in Chronic Pain: An Isobolographic Preclinical Study in Neuropathic Mice.

Authors:  Valeria González; Teresa Pelissier; Victoria Cazanga; Alejandro Hernández; Luis Constandil
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.